HSV-1 TaqMan Probe/Primer and Control Set
CAT:
1111-TM32610
Size:
100 Reactions
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No








HSV-1 TaqMan Probe/Primer and Control Set
Description:
Detection kits for the HSV-1 CE-IVD marked version available for in vitro diagnostic use Available in TaqMan format for analysis Herpes Simplex Virus 1 (HSV-1) is a member of the herpes virus family, Herpesviridae. HSV-1 has a relatively large double-stranded DNA genome. HSVs are primarily transmitted by sexual intercourse, direct contact with lesions or perinatally. Most HSV positive cases are characterised by lesions on the skins and mucous membranes of the mouth and genitals. HSV infection can be either primary or a recurrence of a previous infection. More than 90% of the primary HSV infections are asymptomatic. Primary infection with HSV-1 can lead to gingivostomatitis, eczema herpeticum, keratoconjunctivitis and encephalitis. The primary symptoms of a secondary infection are skin lesions in the nose, mouth and genital regions. The infection is contagious, mainly during an epidemic. HSV-1 TaqMan PCR Kit, 100 reactions Ready to use format, including Master Mix for the target and PCR control to monitor for PCR inhibition and validate the quality Specific Primer and Probe mix for the pathogen/virus/viroid of interest Primer and Probe mix Positive and negative control to confirm the integrity of the kit reagents HSV-1 TaqMan PCR Probe/Primer Set and Controls, 100 reactions Specific Primer/Probe mix and Positive Control for the pathogen/virus/viroid of interest Nuclease-free water Can be used together with Norgen’s PCR Master Mix (#28007) or customer supplied master mix For research use only and NOT intended for in vitro diagnostics.UNSPSC:
41106302HS Code:
3822.19.00.80Dot Regulated:
trueWeight:
30Length:
13Storage Conditions:
Dry Ice -80°C -20°CWidth:
15Height:
12Shelf Life:
2 yearsHazardous Volume:
0Non Hazardous Volume:
0Cubic Feet:
1.3541666666666667
DATASHEET Document
View Document